CARB-X welcomes FDA approval of Zaynich for cUTI patients. This new tool to treat MDR infections demonstrates that breakthrough innovation can emerge from diverse ecosystems around the world – a reminder that addressing AMR requires supporting innovators wherever they are. #IDSky
🔗
For decades, India excelled at making medicines invented elsewhere. With Zaynich, Wockhardt has become the first Indian pharma company to discover, develop, and own an FDA-approved drug
